Bicara Therapeutics Inc

Company News

Recent developments with Bicara Therapeutics Inc (BCAX) have led to the company’s beta value being reach -0.56 cents.

Shaun Noe

Bicara Therapeutics Inc (NASDAQ: BCAX) kicked off on Monday, down -4.85% from the previous trading day, before settling in for ...

Markets

Bicara Therapeutics Inc (BCAX) average volume reaches $517.00K: Are the Stars Lining Up for Investors?

Steve Mayer

Bicara Therapeutics Inc (NASDAQ: BCAX) started the day on Wednesday, with a price decrease of -7.08% at $15.88, before settling ...

Analyst Insights

Bicara Therapeutics Inc (BCAX) volume exceeds 0.75 million: A new investment opportunity for investors

Sana Meer

On Friday, Bicara Therapeutics Inc (NASDAQ: BCAX) opened higher 9.44% from the last session, before settling in for the closing ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.